To include your compound in the COVID-19 Resource Center, submit it here.

Merger ups & downs

Restructuring in Germany is slowly progressing, with companies retooling, spinning out, selling assets and merging. But while one new merger was announced last week, another fell apart - illustrating how difficult it often is to put two companies together.

The merger between neurological play Biofrontera Pharmaceuticals Holding AG and chemistry company Kiadis B.V., which was announced in February, was called off last week after months of negotiations. The transaction, which would

Read the full 704 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers